Article
Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.
Endocrine - 1 Apr 2018
Dimitriadis Georgios K, Randeva Harpal S, Aftab Saboor, Ali Asad, Hattersley John G, Pandey Sarojini, Grammatopoulos Dimitris K, Valsamakis Georgios, Mastorakos Georgios, Jones T Hugh, Barber Thomas M
Abstract excerpt
AIM: To explore the metabolic phenotype of obesity-related secondary hypogonadism (SH) in men pre-replacement and post-replacement therapy with long-acting intramuscular (IM) testosterone undecanoate (TU). METHODS: A prospective observational pilot study on metabolic effects of TU IM in male obesity-related SH (hypogonadal [HG] group, n = 13), including baseline comparisons with controls (eugonadal [EG] group,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.